Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Abstract Background Oral polio vaccine (OPV) containing attenuated serotype 2 polioviruses was globally withdrawn in 2016, and bivalent OPV (bOPV) containing attenuated serotype 1 and 3 polioviruses needs to be withdrawn after the certification of eradication of all wild polioviruses to eliminate fu...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2018-04-01
|
| シリーズ: | BMC Infectious Diseases |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s12879-018-3074-0 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|